The historical rank and industry rank for DanCann Pharma AS's Gross Margin % or its related term are showing as below:
DCPXF'
s Gross Margin % Range Over the Past 10 Years
Min: -743.02 Med: -76.42 Max: -4.76
Current: -51.39
During the past 7 years, the highestGross Margin % of DanCann Pharma AS was -4.76%. The lowest was -743.02%. And the median was -76.42%.
DCPXF's Gross Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 48.54
vs DCPXF: -51.39
DanCann Pharma AS had a gross margin of 5.91% for the quarter that ended in Sep. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for DanCann Pharma AS was 0.00% per year.
DanCann Pharma AS (GREY:DCPXF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
DanCann Pharma AS had a gross margin of 5.91% for the quarter that ended in Sep. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
DanCann Pharma AS Gross Margin % Related Terms
DanCann Pharma AS Gross Margin % Historical Data
* Premium members only.
The historical data trend for DanCann Pharma AS's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DCPXF vs ZTS, UTHR, RGC: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, DanCann Pharma AS's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DanCann Pharma AS Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DanCann Pharma AS's Gross Margin % distribution charts can be found below:
* The bar in red indicates where DanCann Pharma AS's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
DanCann Pharma AS (DCPXF) has a Gross Margin % of 5.91% as of Sep. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on DanCann Pharma AS and its competitors.
Is DanCann Pharma AS's Gross Margin % too high?
DanCann Pharma AS's current Gross Margin % is 5.91%. The Drug Manufacturers industry median Gross Margin % is 48.54. DanCann Pharma AS's value of 5.91% is 87.8% below this industry median. Overall, DanCann Pharma AS has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does DanCann Pharma AS's Gross Margin % compare to ZTS and UTHR?
DanCann Pharma AS's Gross Margin % of 5.91% can be compared against companies in the Drug Manufacturers industry. The industry median Gross Margin % is 48.54. DanCann Pharma AS's value of 5.91% is 87.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DanCann Pharma AS's current Gross Margin % of 5.91% is 87.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on DanCann Pharma AS and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DanCann Pharma AS's current Gross Margin % is 5.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DanCann Pharma AS stock overvalued right now?
DanCann Pharma AS (DCPXF) has a current Gross Margin % of 5.91%. The stock's GF Value™ is $37.14, compared to a current price of $10.00 — trading 73.1% below its estimated fair value. The current Gross Margin % is 5.91% and 87.8% below the Drug Manufacturers industry median of 48.54. DanCann Pharma AS's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For DanCann Pharma AS (DCPXF), the current Gross Margin % is 5.91% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DanCann Pharma AS (DCPXF) Overvalued in 2026?
Based on GuruFocus' analysis, DanCann Pharma AS stock appears to be undervalued.
The current stock price of $10.00 is trading 73.1% below its estimated GF Value™ of $37.14.
Key valuation signals for DCPXF:
Gross Margin %: 5.91%
GF Value™: $37.14 vs. price of $10.00 (73.1% below fair value)
Industry Position: 87.8% below the Drug Manufacturers median
No single metric tells the full story. See the DCPXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
20GF Score
Get the complete analysis for DCPXF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DCPXF has been successfully added to your 
